Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription 09.02.2026 2 Am J Clin Nutr 1 Am J Ophthalmol 1 BMC Ophthalmol 1 BMC Pediatr 1 Circ Cardiovasc Interv 5 Diabet Med 3 Diabetes 5 Diabetes Care 11 Diabetes Obes Metab 6 Diabetologia 2 Invest Ophthalmol Vis Sci 1 J Clin Endocrinol Metab 5 J Diabetes Complications 1 JAMA 2 Nutr Metab (Lond) 2 Ophthalmol Retina 2 Pediatrics 1 PLoS Med 18 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. LEE S, Joehanes R, Huan T, Liu C, et al
   Proteomics Networks Linking Diet to Cardiometabolic Risk Factors: The Framingham Heart Study.
   Am J Clin Nutr. 2025 Dec 1:101131. doi: 10.1016/j.ajcnut.2025.101131.
   PubMed         Abstract available
   
   
2. XIA J, Ge Z, Qian F, Li S, et al
   Addressing Micronutrient Requirements in Type 2 Diabetes: An International Consensus Report.
   Am J Clin Nutr. 2026 Jan 31:101232. doi: 10.1016/j.ajcnut.2026.101232.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. VIGGIANO P, Carra A, Bruno G, Boscia G, et al
   Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy.
   Am J Ophthalmol. 2026 Jan 28:S0002-9394(26)00043.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

4. OWLYA N, Barbosa M, Bartolomeo N, Pannatier-Schuetz Y, et al
   Intravitreal faricimab in patients with refractory diabetic macular edema: 6-month fluid analysis using artificial intelligence.
   BMC Ophthalmol. 2026 Feb 6. doi: 10.1186/s12886-026-04651.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

5. TETIK DINCER B, Urganci N, Koc A, Kup H, et al
   Association of endocrine autoantibodies (anti-TPO, anti-GAD, anti-insulin) with histopathological severity in pediatric Celiac disease: a retrospective cohort study.
   BMC Pediatr. 2025;26:85.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

6. HYDER SN, Seth M, Hamilton DE, Stoute H, et al
   Reno-Protective Effects of SGLT2 Inhibitors in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: Insights From the BMC2 Registry.
   Circ Cardiovasc Interv. 2026 Feb 5:e015645.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. HAGGER V, Hendrieckx C, Cotterill A, Speight J, et al
   Evaluation of a structured type 1 diabetes education program for adolescents and parents: Teens Empowered to Actively Manage Type 1 (TEAM T1).
   Diabet Med. 2026 Feb 5:e70244. doi: 10.1111/dme.70244.
   PubMed         Abstract available
   
   
8. VAN GASTEL A, Graner-Baars M, De Koning EJP, Montori VM, et al
   Picture living with diabetes: A photovoice study of young adults' efforts in making diabetes care fit into their lives.
   Diabet Med. 2026 Feb 5:e70246. doi: 10.1111/dme.70246.
   PubMed         Abstract available
   
   
9. COOPER ZW, Davis GM, Pasquel FJ, Johnson LCM, et al
   Navigating the dual burden of type 1 diabetes and mental illness: A phenomenological study.
   Diabet Med. 2026 Feb 5:e70200. doi: 10.1111/dme.70200.
   PubMed         Abstract available
   
   
10. ZAFAR A, Scarlata C
    Burden of obesity in local health systems: A comparative analysis across three integrated care boards in England with a focus on type 2 diabetes.
    Diabet Med. 2026 Jan 31:e70241. doi: 10.1111/dme.70241.
    PubMed         Abstract available
    
    
11. FRANCESCHI R, Mozzillo E, Marigliano M, Maltoni G, et al
    Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta-analysis.
    Diabet Med. 2026 Jan 31:e70236. doi: 10.1111/dme.70236.
    PubMed         Abstract available
    
    

    
    Diabetes

12. PAGE B
    Diabetes Spotlight: Jay M. Sosenko, MD-Diabetic Neuropathy and Prevention Strategies for Type 1 Diabetes.
    Diabetes. 2026;75:227-228.
    PubMed        
    
    
13. ALCOVER S, Lopez S, Ramos-Regalado L, Munoz-Garcia N, et al
    Erratum. Cardioprotection During Myocardial Infarction in Diabetic Cardiomyopathy. Diabetes 2025;74:1021-1032.
    Diabetes. 2026 Feb 2:db26er04a. doi: 10.2337.
    PubMed         Abstract available
    
    
14. MIRANDA C, Santos C, Tolo J, Gao R, et al
    Erratum. delta-Cells Control a Subset of beta-Cells in Mouse Pancreatic Islets. Diabetes 2025;74:2372-2374.
    Diabetes. 2026 Feb 2:db26er04b. doi: 10.2337.
    PubMed         Abstract available
    
    

    
    Diabetes Care

15. GUO J, Li Z, Patel SA, Chang HH, et al
    Pathophysiological Risk Factors Preceding Incidence of Type 2 Diabetes Subtypes: A Pooled Cohort Study in the United States.
    Diabetes Care. 2026 Feb 6:dc252069. doi: 10.2337/dc25-2069.
    PubMed         Abstract available
    
    
16. LIU L, Peng R, Chu X, Xia Z, et al
    Plasma Metabolite Associations for Risk and Laboratory Measures of Type 2 Diabetes in a Large-Scale Finnish Prospective Cohort.
    Diabetes Care. 2026 Feb 4:dc252201. doi: 10.2337/dc25-2201.
    PubMed         Abstract available
    
    
17. STAFFORD JM, Jaeger B, Casanova R, Demesie Y, et al
    Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the U.S. General Population.
    Diabetes Care. 2026 Feb 2:dc252268. doi: 10.2337/dc25-2268.
    PubMed         Abstract available
    
    
18. MCCORMICK N, Burrack N, Yokose C, Lu N, et al
    Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.
    Diabetes Care. 2026 Jan 30:dc251713. doi: 10.2337/dc25-1713.
    PubMed         Abstract available
    
    
19. BONNET JB, Huguet H, Avignon A, Duflos C, et al
    GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study.
    Diabetes Care. 2026 Jan 30:dc252120. doi: 10.2337/dc25-2120.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. SU Q, Huang WZ, Huang Y, Mo LR, et al
    Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70528.
    PubMed         Abstract available
    
    
21. JANUSZEWSKI AS, Snaith JR, Kowalski GM, Bruce CR, et al
    Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkers.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70517.
    PubMed         Abstract available
    
    
22. MCKAY B, El Chaar D, Paquette M, Vallis M, et al
    Rationale and design of a parallel randomised trial of a plant-based intensive lifestyle intervention for diabetes remission: The REmission of diabetes using a PlAnt-based weight loss InteRvention (REPAIR) trial.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70510.
    PubMed         Abstract available
    
    
23. KUGATHASAN L, Tsoukas MA, Nardone M, Sridhar VS, et al
    Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70525.
    PubMed        
    
    
24. 
    Correction to "Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes-The Steady Sugar trial".
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70544.
    PubMed        
    
    
25. SHAO JW, Yang Y, Zhang YQ, Dai HY, et al
    Early detection of type 2 diabetes mellitus-associated cognitive dysfunction: The potential of amide proton transfer-weighted imaging.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70468.
    PubMed         Abstract available
    
    
26. KIM SR, Hong JH, Kim SG, Kim SK, et al
    Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.
    Diabetes Obes Metab. 2026 Feb 3. doi: 10.1111/dom.70527.
    PubMed         Abstract available
    
    
27. LI XY, Jin Y, Feng XY, Wang RC, et al
    Prevalence and predictors of residual gastric content in patients with type 2 diabetes on GLP-1 receptor agonists: A prospective observational study.
    Diabetes Obes Metab. 2026 Feb 3. doi: 10.1111/dom.70537.
    PubMed         Abstract available
    
    
28. ARDAKANI J, Shahid I, Gullapelli R, Ahmed EN, et al
    Transportation noise exposure and incident type 2 diabetes: A retrospective cohort study in a large U.S. healthcare system.
    Diabetes Obes Metab. 2026 Feb 6. doi: 10.1111/dom.70499.
    PubMed         Abstract available
    
    
29. TAN JY, Nalbandian C, Moran C, Zhou Z, et al
    Single versus repeat diabetes testing in older adults: Observations from the STAREE clinical trial.
    Diabetes Obes Metab. 2026 Feb 6. doi: 10.1111/dom.70539.
    PubMed        
    
    
30. WEI Y, Tian Y, Cui R, Wang Y, et al
    Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes.
    Diabetes Obes Metab. 2026 Feb 2. doi: 10.1111/dom.70513.
    PubMed         Abstract available
    
    

    
    Diabetologia

31. LAMPOUSI AM, Zeng J, Lofvenborg JE, Carlsson S, et al
    Red meat intake during pregnancy and childhood and risk of type 1 diabetes: findings from the ABIS birth cohort.
    Diabetologia. 2026 Feb 7. doi: 10.1007/s00125-026-06671.
    PubMed         Abstract available
    
    
32. TRINK J, Gao B, Li R, Patel JH, et al
    LASP1 mediates ADAM17 upregulation in high glucose to promote fibrosis in diabetic kidneys.
    Diabetologia. 2026 Feb 6. doi: 10.1007/s00125-025-06662.
    PubMed         Abstract available
    
    
33. SEBASTIAN-VALLES F, Sager-La Ganga C, Justel Enriquez A, Jimenez Blanco S, et al
    Analysis of glycaemic control and treatment satisfaction with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06674.
    PubMed         Abstract available
    
    
34. BLACK SKP, Tully A, Davis EA, Roberts A, et al
    Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06668.
    PubMed         Abstract available
    
    
35. COUPER JJ, Oakey H, Penno MAS, Wentworth JM, et al
    Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.
    Diabetologia. 2026;69:631-642.
    PubMed         Abstract available
    
    
36. JIANG Y, Wu D, Ni Y, Liu Y, et al
    Peptide hormone spexin restores beta cell function and improves glycaemic control in mice via regulation of the sodium-potassium pump.
    Diabetologia. 2026;69:710-726.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

37. BUSZA AM, Kakihara S, Zhuang K, Yamaguchi TC, et al
    Baseline Nonperfusion and Deep Capillary Plexus Ischemia Predict Two-Year Retinal Nonperfusion Progression in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:64.
    PubMed         Abstract available
    
    
38. LESSIEUR EM, Saadane A, Du Y, Kiser J, et al
    Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:8.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

39. 
    Correction to: "Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA".
    J Clin Endocrinol Metab. 2026 Feb 6:dgag013. doi: 10.1210.
    PubMed        
    
    

    
    J Diabetes Complications

40. PATOULIAS D, Muzurovic E, Maggio V, Rizzo M, et al
    Extending beyond established cardiometabolic benefits of empagliflozin in type 2 diabetes: the evolving paradigm of glycemic variability.
    J Diabetes Complications. 2026 Feb 3:109276. doi: 10.1016/j.jdiacomp.2026.109276
    PubMed        
    
    
41. XIANG Y, Tang X, Xiao Y, Li X, et al
    Treatment-related progression of subclinical atherosclerosis in latent autoimmune diabetes in adults: A two-year longitudinal study.
    J Diabetes Complications. 2026;40:109269.
    PubMed         Abstract available
    
    
42. TAN SHE, Gan PJQ, Yeoh E, Liu AYL, et al
    Effectiveness and acceptability of continuous glucose monitoring in the detection of hypoglycaemia among renal dialysis patients with diabetes mellitus: A pilot study.
    J Diabetes Complications. 2026;40:109267.
    PubMed         Abstract available
    
    
43. LOW S, Moh A, Zheng H, Goh KS, et al
    Understanding the role of triglyceride glucose-body roundness index (TyG-BRI) in the paradigm of cognitive decline over time in patients with type 2 diabetes.
    J Diabetes Complications. 2026;40:109270.
    PubMed         Abstract available
    
    
44. GLASER N, Chaffin Z, Tancredi D, Rewers A, et al
    Inflammatory profile associated with hyperglycemia in children with type 1 diabetes.
    J Diabetes Complications. 2026;40:109275.
    PubMed         Abstract available
    
    

    
    JAMA

45. ANDERER S
    High-Dose Flu Vaccine Demonstrates Benefits in Older Adults With Diabetes.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26366.
    PubMed        
    
    

    
    Nutr Metab (Lond)

46. DONG J, Zhang Y, Li YL, Wu LJ, et al
    Insulin signaling pathway related m(6)A methylated biomarker for type 2 diabetes and the potential modulation mechanism.
    Nutr Metab (Lond). 2026 Jan 31. doi: 10.1186/s12986-026-01086.
    PubMed        
    
    
47. YIN Y, Ye M, Shi M, Miao Z, et al
    Association of plant-based diet with the risk of large-for-gestational-age birth in women with gestational diabetes mellitus.
    Nutr Metab (Lond). 2026 Feb 5. doi: 10.1186/s12986-026-01092.
    PubMed        
    
    

    
    Ophthalmol Retina

48. CHEN R, Xu K, Zheng K, Zhang W, et al
    Noninvasive Synthesis of Multiframe Ultra-Widefield Fluorescein Angiography from Color Fundus Photographs.
    Ophthalmol Retina. 2026;10:176-184.
    PubMed         Abstract available
    
    
49. HONG AT, Luu IY, Keenan JD, Stewart JM, et al
    Long-Term Metformin Use and Reduced Risk of Age-Related Macular Degeneration: A Large Database Study.
    Ophthalmol Retina. 2025 Aug 11:S2468-6530(25)00354.
    PubMed         Abstract available
    
    

    
    Pediatrics

50. KISS S, Juhasz MF, Koi T, Ocskay K, et al
    CFTR Modulator Therapy and Glycemic Control: A Meta-Analysis.
    Pediatrics. 2026;157:e2024070328.
    PubMed         Abstract available
    
    
51. DRIOLLET B, Ahmed AM, Hutcheon JA, Buajitti E, et al
    Maternal Diabetes and Risk of Epilepsy in Offspring.
    Pediatrics. 2026 Feb 4:e2025071138. doi: 10.1542/peds.2025-071138.
    PubMed         Abstract available
    
    

    
    PLoS Med

52. DOUGLAS LJ, Gamble GD, Harding JE, Samuel D, et al
    Mother and child health 4.5 years after gestational diabetes mellitus managed using tight or less tight targets for glycaemic control: Post-hoc follow-up study of the TARGET trial.
    PLoS Med. 2026;23:e1004635.
    PubMed         Abstract available
    
    

    
    PLoS One

53. ZAVERI K, Kulkarni G, Nair R, Shanmugan G, et al
    GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes.
    PLoS One. 2026;21:e0337107.
    PubMed         Abstract available
    
    
54. YUAN Z, Jeffcoat CH, Ali SR, Sena AG, et al
    Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching.
    PLoS One. 2026;21:e0341745.
    PubMed         Abstract available
    
    
55. HU L, Liu J, Yang X, Teng C, et al
    Leveraging videos and community health workers to address social determinants of health in immigrants (LINK-IT): Protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0341217.
    PubMed         Abstract available
    
    
56. ROTHLIN-ZACHRISSON N, Strom Holst B, Ohlund M, Leksell J, et al
    In sickness and health: A reflexive thematic analysis of ethical considerations and experiences of owners of cats treated for diabetes mellitus.
    PLoS One. 2026;21:e0341759.
    PubMed         Abstract available
    
    
57. MBWAMBO DP, Mikomangwa W, Mkugwe RH, Mallya B, et al
    Skin-related adverse events and their associated factors among Diabetic patients on insulin therapy.
    PLoS One. 2026;21:e0320556.
    PubMed         Abstract available
    
    
58. BIAN L, Yang C, Jin Y, Wang H, et al
    Association between carbohydrate quality and glycemic control in individuals with type 1 diabetes: A cross-sectional and meal-based analysis.
    PLoS One. 2026;21:e0341915.
    PubMed         Abstract available
    
    
59. MUKASA RJ, Mubiru N, Sekitoleko I, Makanga R, et al
    Comparative assessment of the impact of iron deficiency on HbA1c accuracy in non-anaemic individuals with type 2 diabetes: A secondary data analysis.
    PLoS One. 2026;21:e0323034.
    PubMed         Abstract available
    
    
60. ZHU G, Qu Y, Chen K, He D, et al
    Comparison of the triglyceride-glucose index and triglyceride-glucose-body mass index for predicting non-alcoholic fatty liver disease in elderly diabetic patients.
    PLoS One. 2026;21:e0341109.
    PubMed         Abstract available
    
    
61. KIM S, Kim K
    Combined association of socioeconomic status and type 2 diabetes with influenza vaccination in older adults: A cross-sectional analysis of the Korea National Health and Examination Survey (2019-2022).
    PLoS One. 2026;21:e0341831.
    PubMed         Abstract available
    
    
62. 
    Expression of Concern: Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients.
    PLoS One. 2026;21:e0342146.
    PubMed        
    
    
63. ALI H, Jan A, Ali G, Ali SS, et al
    Assessment of antidiabetic, hepatoprotective, and analgesic effects of quinazolinone derivative, (E)-1-Benzoyl-3-((4- (Dimethylamino) Benzylidene) Amino)-2-(4-(Dimethylamino) Phenyl)-2,3 dihydroquinazoline-4(1h)-one, in diabetes induced mice model.
    PLoS One. 2026;21:e0327627.
    PubMed         Abstract available
    
    
64. EDAE CK, Bedada AT, Teklemariam MD, Tolesa MB, et al
    A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia.
    PLoS One. 2026;21:e0340457.
    PubMed         Abstract available
    
    
65. WANG X, Ma R, Lou D, Li H, et al
    Ursolic acid alleviates liver injury in diabetic mice induced by high-fat diet combined with streptozotocin via the NLRP3 signaling pathway.
    PLoS One. 2026;21:e0340643.
    PubMed         Abstract available
    
    
66. AHABWENKI R, Piloya T, Namiiro F, Muzeyi W, et al
    Impact of COVID-19 on New - onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda.
    PLoS One. 2026;21:e0341145.
    PubMed         Abstract available
    
    
67. ROTHLIN-ZACHRISSON N, Strom Holst B, Ohlund M, Leksell J, et al
    To treat or not to treat: Experiences and considerations of veterinarians in management of cats with diabetes mellitus.
    PLoS One. 2026;21:e0341762.
    PubMed         Abstract available
    
    
68. AGYARE G, Courtin D, Asamoah Sakyi S, Nakotey GK, et al
    Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens.
    PLoS One. 2026;21:e0341659.
    PubMed         Abstract available
    
    
69. METTANANDA C, Ranawaka C, Egodage T, Dantanarayana C, et al
    Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.
    PLoS One. 2026;21:e0341364.
    PubMed         Abstract available
    
    
70. SIKET M, Kovacs L, Eigner G
    Stochastic virtual population in type 1 diabetes.
    PLoS One. 2026;21:e0341034.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum